GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Antibody Patient Onset (days) Symptom GlyTouCan Arbitrary Fluorescence Units (AFU)
IgA
Patient 1
10
moderate
382
IgA
Patient 1
10
moderate
367
IgA
Patient 1
10
moderate
390
IgA
Patient 1
10
moderate
329
IgA
Patient 1
10
moderate
229
IgA
Patient 1
10
moderate
450
IgA
Patient 1
10
moderate
432
IgA
Patient 1
10
moderate
348
IgA
Patient 1
10
moderate
316
IgA
Patient 1
10
moderate
352
Displaying entries 1 - 10 of 4050 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01